These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35165727)

  • 21. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
    Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tedizolid population pharmacokinetics, exposure response, and target attainment.
    Flanagan S; Passarell J; Lu Q; Fiedler-Kelly J; Ludwig E; Prokocimer P
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6462-70. PubMed ID: 25136028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man.
    Barber AE; Coyle SM; Marano MA; Fischer E; Calvano SE; Fong Y; Moldawer LL; Lowry SF
    J Immunol; 1993 Mar; 150(5):1999-2006. PubMed ID: 8436830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of tedizolid, sutezolid, and sutezolid-M1 in non-human primates.
    Kim S; Scanga CA; Miranda Silva C; Zimmerman M; Causgrove C; Stein B; Dartois V; Peloquin CA; Graham E; Louie A; Flynn JL; Schmidt S; Drusano GL
    Eur J Pharm Sci; 2020 Aug; 151():105421. PubMed ID: 32531349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers.
    Holz O; Tan L; Schaumann F; Müller M; Scholl D; Hidi R; McLeod A; Krug N; Hohlfeld JM
    Pulm Pharmacol Ther; 2015 Dec; 35():50-9. PubMed ID: 26545873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis.
    Park AYJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects.
    Lodise TP; Bidell MR; Flanagan SD; Zasowski EJ; Minassian SL; Prokocimer P
    J Antimicrob Chemother; 2016 Sep; 71(9):2553-8. PubMed ID: 27317442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.
    Astiz ME; Rackow EC; Still JG; Howell ST; Cato A; Von Eschen KB; Ulrich JT; Rudbach JA; McMahon G; Vargas R
    Crit Care Med; 1995 Jan; 23(1):9-17. PubMed ID: 8001393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxemia and acute-phase proteins in major abdominal surgery.
    Buttenschoen K; Buttenschoen DC; Berger D; Vasilescu C; Schafheutle S; Goeltenboth B; Seidelmann M; Beger HG
    Am J Surg; 2001 Jan; 181(1):36-43. PubMed ID: 11248174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics of tedizolid in rat plasma and cerebrospinal fluid.
    Gu L; Ma M; Zhang Y; Zhang L; Zhang S; Huang M; Zhang M; Xin Y; Zheng G; Chen S
    Regul Toxicol Pharmacol; 2019 Oct; 107():104420. PubMed ID: 31295511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a single dose of orally and rectally administered misoprostol in an in vivo endotoxemia model in healthy adult horses.
    Kimura S; McCoy AM; Boothe DM; Wooldridge AA; Graff E; Hammack SM; Cresci L; Hofmeister E; Lascola KM
    Am J Vet Res; 2022 Jun; 83(8):. PubMed ID: 35895797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans.
    Pajkrt D; Manten A; van der Poll T; Tiel-van Buul MM; Jansen J; Wouter ten Cate J; van Deventer SJ
    Blood; 1997 Aug; 90(4):1415-24. PubMed ID: 9269759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
    Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
    Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell dynamics during experimental endotoxemia in humans.
    Brinkhoff A; Zeng Y; Sieberichs A; Dolff S; Shilei X; Sun M; Engler H; Benson S; Korth J; Schedlowski M; Kribben A; Witzke O; Wilde B
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
    Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
    Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.
    Geven C; van Lier D; Blet A; Peelen R; Ten Elzen B; Mebazaa A; Kox M; Pickkers P
    Br J Clin Pharmacol; 2018 Sep; 84(9):2129-2141. PubMed ID: 29856470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
    Moran GJ; Fang E; Corey GR; Das AF; De Anda C; Prokocimer P
    Lancet Infect Dis; 2014 Aug; 14(8):696-705. PubMed ID: 24909499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.